Understanding the causes of multidrug resistance in cancer: a comparison of doxorubicin and sunitinib
作者： Henk J. Broxterman , Kristy J. Gotink , Henk M.W. Verheul
DOI: 10.1016/J.DRUP.2009.07.001
关键词:
摘要: … molecular mechanisms of multiple drug resistance began. … role of drug efflux transporters in anticancer drug resistance … either quantitatively their contribution to the drug resistance of the …
vumc.nl
elsevier.com
sci-hub.se 参考文章(226)
Cyrus M. Ghajar, Roland Meier, Mina J. Bissell, Quis custodiet ipsos custodies: who watches the watchmen? American Journal of Pathology. ,vol. 174, pp. 1996- 1999 ,(2009) , 10.2353/AJPATH.2009.090363
Peter R. Wielinga, Hans V. Westerhoff, Jan Lankelma, The relative importance of passive and P‐glycoprotein mediated anthracycline efflux from multidrug‐resistant cells FEBS Journal. ,vol. 267, pp. 649- 657 ,(2000) , 10.1046/J.1432-1327.2000.01030.X
H.M. Pinedo, E.G.E. de Vries, C.M. Kuiper, J. Lankelma, N. Feller, H.J. Broxterman, C.H.M. Versantvoort, Energy-dependent processes involved in reduced drug accumulation in multidrug-resistant human lung cancer cell lines without P-glycoprotein expression. Cancer Research. ,vol. 52, pp. 17- 23 ,(1992)
Herbert M. Pinedo, Sabine C. Linn, Catharina M. Kuiper, Corrie Popp-Snijders, Bert G. Wolthers, Hendrick M W Verheul, Klaas Hoekman, Nicole Feller, A Patient with Adrenocortical Carcinoma: Characterization of Its Biological Activity and Drug Resistance Profile Clinical Cancer Research. ,vol. 3, pp. 389- 394 ,(1997)
Selection of Chromosomal Variant in Amethopterin-Resistant Sublines of Leukemia L1210 With Increased Levels of Dihydrofolate Reductase Journal of the National Cancer Institute. ,vol. 31, pp. 575- 601 ,(1963) , 10.1093/JNCI/31.3.575
Piet Borst, Sven Rottenberg, Cancer cell death by programmed necrosis Drug Resistance Updates. ,vol. 7, pp. 321- 324 ,(2004) , 10.1016/J.DRUP.2004.11.003
Paul Dent, David T. Curiel, Paul B. Fisher, Steven Grant, Synergistic combinations of signaling pathway inhibitors: mechanisms for improved cancer therapy. Drug Resistance Updates. ,vol. 12, pp. 65- 73 ,(2009) , 10.1016/J.DRUP.2009.03.001
Annamaria Rapisarda, Giovanni Melillo, Role of the hypoxic tumor microenvironment in the resistance to anti-angiogenic therapies Drug Resistance Updates. ,vol. 12, pp. 74- 80 ,(2009) , 10.1016/J.DRUP.2009.03.002
Robert W. Robey, Kenneth K.K. To, Orsolya Polgar, Marius Dohse, Patricia Fetsch, Michael Dean, Susan E. Bates, ABCG2: A perspective Advanced Drug Delivery Reviews. ,vol. 61, pp. 3- 13 ,(2009) , 10.1016/J.ADDR.2008.11.003
Trevor W. Hambley, Is anticancer drug development heading in the right direction Cancer Research. ,vol. 69, pp. 1259- 1262 ,(2009) , 10.1158/0008-5472.CAN-08-3786